Key Market Indicators
Sales of diabetes medicine in Greece are expected to reach $603 million by 2026, up 1.8% year-on-year on average since 2003. In 2021, Greece was ranked 7th globally, behind Australia with sales of $551.87 million. Canada, Spain and Italy took the 2nd, 3rd and 4th places, respectively. Import of insulin in Greece is projected to reach $63.6 million by 2026, an increase of 0.8% year-on-year on average since 1993. During this period, demand for the product has fallen by 1.4% annually. Exports of insulin from Greece are expected to reach $7.25 million by 2026, with an average annual growth rate of 4.3% since 1993. In 2021, the nation was ranked 23rd, behind Argentina with exports of $5.75 million. France, Italy and China claimed the 2nd, 3rd and 4th spots, respectively.
